- Home
- CODA vs MNOV Comparison
CODA vs MNOV Comparison
Compare CODA & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- MNOV
- Stock Information
- Founded
- CODA 1994
- MNOV 2000
- Country
- CODA United States
- MNOV United States
- Employees
- CODA N/A
- MNOV N/A
- Industry
- CODA Industrial Machinery/Components
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- MNOV Health Care
- Exchange
- CODA Nasdaq
- MNOV Nasdaq
- Market Cap
- CODA 88.7M
- MNOV 68.2M
- IPO Year
- CODA N/A
- MNOV 2005
- Fundamental
- Price
- CODA $8.25
- MNOV $1.28
- Analyst Decision
- CODA Strong Buy
- MNOV Strong Buy
- Analyst Count
- CODA 1
- MNOV 2
- Target Price
- CODA $11.00
- MNOV $7.00
- AVG Volume (30 Days)
- CODA 59.7K
- MNOV 17.6K
- Earning Date
- CODA 06-16-2025
- MNOV 08-07-2025
- Dividend Yield
- CODA N/A
- MNOV N/A
- EPS Growth
- CODA 21.86
- MNOV N/A
- EPS
- CODA 0.30
- MNOV N/A
- Revenue
- CODA $22,758,966.00
- MNOV N/A
- Revenue This Year
- CODA $30.82
- MNOV N/A
- Revenue Next Year
- CODA $20.84
- MNOV N/A
- P/E Ratio
- CODA $27.29
- MNOV N/A
- Revenue Growth
- CODA 24.78
- MNOV N/A
- 52 Week Low
- CODA $5.76
- MNOV $1.12
- 52 Week High
- CODA $9.89
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- CODA 57.37
- MNOV 39.32
- Support Level
- CODA $7.81
- MNOV $1.32
- Resistance Level
- CODA $8.50
- MNOV $1.38
- Average True Range (ATR)
- CODA 0.41
- MNOV 0.04
- MACD
- CODA -0.01
- MNOV 0.00
- Stochastic Oscillator
- CODA 63.45
- MNOV 8.33
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.